This study is looking at how special nerves in your muscles, called Group III/IV afferents, affect your breathing and body temperature when you exercise. These nerves send signals to your brain about what your muscles are doing. Researchers want to see if blocking these signals with a drug during cycling exercise changes how your airways respond and how much you sweat and your skin blood flow. They will measure these responses after two weeks. You can join if you are between 18 and 40 years old, physically active, and meet certain fitness levels. You cannot participate if you smoke, have asthma, diabetes, or certain other health conditions. The study aims to understand how these muscle nerves help your body handle the demands of exercise.

Study design

This is an interventional study planning to enroll 15 participants. It involves exercise training with or without a medication that blocks Group III/IV afferent feedback.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Your airway resistance, sweat rate, and skin blood flow will be measured at 2 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.